Dis-Chem Pharmacies First Half 2024 Earnings: EPS: R0.58 (vs R0.70 in 1H 2023)

Dis-Chem Pharmacies (JSE:DCP) First Half 2024 Results

Key Financial Results

• Revenue: R17.9b (up 9.4% from 1H 2023).
• Net income: R500.9m (down 17% from 1H 2023).
• Profit margin: 2.8% (down from 3.7% in 1H 2023). The decrease in margin was driven by higher expenses.
• EPS: R0.58 (down from R0.70 in 1H 2023).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Dis-Chem Pharmacies Earnings Insights

Looking ahead, revenue is forecast to grow 8.4% p.a. on average during the next 3 years, compared to a 8.0% growth forecast for the Consumer Retailing industry in South Africa.

Performance of the South African Consumer Retailing industry.

The company's shares are up 5.9% from a week ago.

Balance Sheet Analysis

Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. See our latest analysis on Dis-Chem Pharmacies' balance sheet health.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.